NEW YORK (GenomeWeb News) — Tripos has sold four buildings at its Bude, UK, Discovery Research location to real estate investors and Park Research, a local chemistry company, according to a Securities and Exchange Commission filing last week.
 
The move, part of Tripos’ plan to sell its chemical research units, enabled the company to recognize around $1.3 million in gross proceeds.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.